Temporary Medicare weight-management program
Medicare GLP-1 Bridge: $50 GLP-1 Drugs for Weight Loss
The Medicare GLP-1 Bridge gives certain people with Medicare Part D access to selected weight-management drugs for a $50 copay per one-month supply from July 1, 2026, through December 31, 2027.
The short answer: The Medicare GLP-1 Bridge is a temporary, nationwide CMS program for certain adults who have Medicare Part D drug coverage and meet specific weight-management criteria. Approved beneficiaries pay $50 for a 28- or 30-day supply of a covered GLP-1 drug.
This is not ordinary Part D formulary coverage. The Bridge operates outside the normal Part D payment system, so its $50 copay does not satisfy a drug-plan deductible or count toward Part D true out-of-pocket spending, commonly called TrOOP.
The essentials
Medicare GLP-1 Bridge at a Glance
$50 Monthly Copay
Eligible beneficiaries pay $50 for one 28- or 30-day supply, regardless of income level.
Part D Is Required
You must be enrolled in an eligible standalone drug plan or Medicare health plan that includes Part D coverage.
Temporary Program
The demonstration began July 1, 2026, and is currently scheduled to continue through December 31, 2027.
You do not enroll in the Bridge during AEP. Access is based on your current Part D coverage, the clinical requirements and a prior authorization submitted by your medical provider. A Part D plan sponsor does not have to opt into the program.
Clinical requirements
Who Qualifies for the Medicare GLP-1 Bridge?
Your provider must prescribe the drug to reduce excess body weight and maintain weight reduction together with an ongoing lifestyle program involving structured nutrition and physical activity. You must be at least 18 and meet one of the following standards when GLP-1 therapy begins.
BMI of 35 or Higher
No additional listed condition is required under this eligibility pathway.
BMI of 30 or Higher
You must also have at least one of these:
- Heart failure with preserved ejection fraction;
- Uncontrolled hypertension despite treatment with two blood-pressure medications; or
- Chronic kidney disease at stage 3a or higher.
BMI of 27 or Higher
You must also have at least one of these:
- Prediabetes;
- A previous heart attack;
- A previous stroke; or
- Symptomatic peripheral artery disease.
Already taking a GLP-1? The BMI and related health criteria are measured at the time you first began GLP-1 therapy. Your current BMI may be lower if the treatment has been effective, but your provider must be able to attest that you met the criteria when therapy started.
The Bridge is not the route for every GLP-1 prescription. You are not eligible if you already receive a GLP-1 through your Part D plan. People using a GLP-1 for type 2 diabetes, moderate-to-severe obstructive sleep apnea or an eligible metabolic dysfunction-associated steatohepatitis—MASH—indication should pursue coverage through their regular Part D plan instead.
Covered medications
Which GLP-1 Drugs Does the Bridge Cover?
CMS currently lists three products when they are prescribed for the Bridge’s weight-management use. The product list may change during the demonstration.
| Covered drug | Covered formulation | Important limitation |
|---|---|---|
| Foundayo® | Tablet formulations | Must be prescribed for a qualifying weight-management use under the Bridge. |
| Wegovy® | Injection or tablet formulations | Normal Part D rules apply instead when the prescription is for a Part D-covered indication. |
| Zepbound® | KwikPen® only | Single-dose Zepbound pens and vials are not covered by the Bridge. |
Pen needles are separate. Medicare GLP-1 Bridge does not cover the pen needles used with the Zepbound KwikPen. They must be purchased separately.
What the $50 does—and does not—do
How the Bridge Copay Affects Your Part D Costs
Because the Bridge sits outside the regular Part D payment flow, its cost rules are different from the deductible and out-of-pocket rules explained in our guide to Medicare deductibles and maximum out-of-pocket limits.
| Cost question | Medicare GLP-1 Bridge rule |
|---|---|
| Copay | $50 for one 28- or 30-day supply |
| Part D deductible | The deductible does not apply to the Bridge fill. |
| Part D TrOOP | The $50 payment does not count toward your annual Part D out-of-pocket total. |
| Extra Help or LIS | The low-income subsidy does not reduce the Bridge copay below $50. |
| Medicare Prescription Payment Plan | Bridge drugs are not eligible for payment-plan billing. |
| Extended supplies | Sixty- and 90-day fills are not available through the Bridge. |
Bridge versus plan coverage
How Is This Different From Normal Medicare Part D?
| Feature | Medicare GLP-1 Bridge | Regular Part D coverage |
|---|---|---|
| Purpose | Selected GLP-1 drugs for qualifying weight-management use | Drugs prescribed for Medicare-covered medical indications and listed or approved under the plan’s rules |
| Who processes coverage | A central CMS processor handles authorization and claims | Your Part D plan applies its formulary and coverage rules |
| Member cost | $50 for one monthly supply | Depends on the plan’s deductible, tier, pharmacy and coverage rules |
| Annual Part D spending | The $50 does not count toward TrOOP | Qualifying member payments generally count under Part D rules |
| Program duration | Temporary: July 1, 2026, through December 31, 2027 | Part D is an ongoing Medicare benefit, although plans and formularies change annually |
Many Medicare Advantage plans include Part D and are called MAPD plans. Beneficiaries with eligible MAPD, SNP, employer-group or LI NET coverage may qualify if they also satisfy the Bridge’s clinical criteria. People enrolled in a D-SNP are not automatically excluded merely because they also receive Medicaid.
Getting started
How to Get a GLP-1 Through the Medicare Bridge
- Talk with your medical provider. Your provider must decide whether a covered GLP-1 is medically appropriate and whether you appear to meet the Bridge criteria.
- Your provider sends the prescription. The prescription must be for one of the covered products and for the qualifying weight-management use.
- The pharmacy routes the claim. The pharmacy may ask for your Medicare Number—or, if needed, the last four digits of your Social Security number—to locate it.
- Your provider completes prior authorization. The request may be handled electronically or by fax. A denial from your regular Part D plan is not required before the request goes to the Bridge.
- Medicare communicates the decision. You receive a mailed notice, and the prescriber receives the approval or denial electronically or by fax. Once approved, you pay $50 for a one-month supply.
Prior-authorization approval remains valid through December 31, 2027, for refills and dose changes involving the same covered drug. Switching from one covered GLP-1 product to another requires a new authorization.
Common questions
Medicare GLP-1 Bridge FAQ
Does the Medicare GLP-1 Bridge cover Ozempic or Mounjaro?
No. CMS currently lists Foundayo, Wegovy and the Zepbound KwikPen for the Bridge. A different GLP-1 may be covered by a Part D plan when prescribed for a Medicare-covered indication, such as type 2 diabetes.
Can someone with Original Medicare use the Bridge?
Yes, if the person also has an eligible standalone Part D plan and meets every other Bridge requirement. Original Medicare without Part D drug coverage is not enough.
Can someone with a Medicare Advantage plan qualify?
Yes, many HMO, HMO-POS and local or regional PPO Medicare Advantage plans that include Part D are eligible plan types. Some less-common plan types are excluded unless the person also has an eligible standalone Part D plan.
Can someone with Medicaid or Extra Help qualify?
Yes, dual-eligible beneficiaries may qualify when they have an eligible Part D plan type and meet the clinical criteria. However, Extra Help does not lower the Bridge’s $50 copay.
What if my BMI is now below the required level?
The criteria apply when GLP-1 therapy began. Your provider may attest to the BMI and qualifying conditions that existed at initiation, even if your BMI is lower when the prior authorization is submitted.
Can a prior-authorization denial be appealed?
The Bridge does not provide a formal appeals process. If information was incorrect, incomplete or has changed, the prescriber may submit the prior-authorization form again with corrected or additional information.
Do I need to change Part D plans to use the Bridge?
Not solely because a carrier did not opt in—the Bridge is administered separately from participating Part D plans. You still must be enrolled in an eligible Part D plan type. Do not change coverage without reviewing all of your doctors, prescriptions, pharmacies and plan rules.
Official information
Medicare and CMS Resources
The Bridge is temporary, and CMS may update the covered-product list or operational guidance. Check current official information before relying on any particular drug or eligibility pathway.
- Medicare.gov: Weight-loss drugs and GLP-1 Bridge eligibility
- CMS: Medicare GLP-1 Bridge overview and current FAQs
- CMS: Information for prescribers and prior authorization
Need Help Understanding How Your Drug Coverage Fits?
I can help you identify whether you have standalone Part D or an MAPD plan, explain how your plan normally handles prescriptions and review your broader Medicare coverage. Your medical provider and Medicare—not Thompson Medicare Brokerage—determine clinical Bridge eligibility and authorization.
This article provides general educational information and is not medical advice or an eligibility determination. Drug coverage, program rules and covered products may change. Consult your healthcare provider, Medicare and your prescription drug plan for guidance specific to your situation. Thompson Medicare Brokerage is an independent insurance agency and is not connected with or endorsed by the United States government or the federal Medicare program.